milestone
Leukemia Vaccine Passes Key Trial, Adding to Breakthrough Year for Cancer Drugs
A news report on November 18 says a leukemia vaccine passed a key trial, cited as part of a breakthrough year for cancer drugs. The feed summary does not state whether the vaccine is mRNA-based, the trial phase, or the sponsor; these remain unverified.
Sources
- T2Google NewsMajorwestern